Evidence map›Paper›PMID 33188278›Full record

ArticleNature medicine2020

Dysregulated ribonucleoprotein granules promote cardiomyopathy in RBM20 gene-edited pigs.

Jay W Schneider, Saji Oommen, Muhammad Y Qureshi, Sean C Goetsch, David R Pease, Rhianna S Sundsbak, Wei Guo, Mingming Sun, Han Sun, Hidehito Kuroyanagi and 17 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. RBM20 variants disrupt CaSignal transduction and targeted therapy · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. The Role of Stress Granules in Cardiovascular Diseases.Reviews in cardiovascular medicine · 2026
    Review
  13. Article
  14. Enhancer Dynamics for Gene Regulation in the Cardiovascular System.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 10 institutions in 4 countries.

Jay W SchneiderDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA. schneider.jay1@mayo.edu.ORCID http://orcid.org/0000-0002-7386-9343
Saji OommenDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-6824-4894
Muhammad Y QureshiDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-9898-2318
Sean C GoetschHamon Center for Regenerative Science and Medicine, Department of Medicine/Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
David R PeaseDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-0472-1900
Rhianna S SundsbakDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.
Wei GuoDepartment of Animal Science, University of Wyoming, Laramie, WY, USA.ORCID http://orcid.org/0000-0002-9158-8107
Mingming SunDepartment of Animal Science, University of Wyoming, Laramie, WY, USA.ORCID http://orcid.org/0000-0002-3117-7066
Han SunDepartment of Genetics and Genome Center, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-3390-0027
Hidehito KuroyanagiLaboratory of Gene Expression, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Dennis A WebsterRecombinetics, St. Paul, MN, USA.
Alexander W CouttsRecombinetics, St. Paul, MN, USA.
Kimberly A HolstDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.
Brooks S EdwardsDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.
Nikolas NewvilleDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.
Matthew A HathcockDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.
Tamene MelkamuRecombinetics, St. Paul, MN, USA.
Francesca BrigantiDepartment of Genetics and Genome Center, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-5738-2642
Wu WeiDepartment of Genetics and Genome Center, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-5643-8739
Maria G RomanelliDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.ORCID http://orcid.org/0000-0002-7360-1195
Scott C FahrenkrugRecombinetics, St. Paul, MN, USA.
Doug E FrantzDepartment of Chemistry, University of Texas at San Antonio, San Antonio, TX, USA.ORCID http://orcid.org/0000-0002-4509-4579
Timothy M OlsonDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.
Lars M SteinmetzDepartment of Genetics and Genome Center, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-3962-2865
Daniel F CarlsonRecombinetics, St. Paul, MN, USA. dan@recombinetics.com.ORCID http://orcid.org/0000-0001-6095-2108
Timothy J NelsonDiscovery Engine/Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, USA.
Wanek Program Preclinical Pipeline
Mayo Clinic · USMayo Clinic in Arizona · USRecombinetics (United States) · USEuropean Molecular Biology Laboratory · DEStanford University · USUniversity of Wyoming · USThe University of Texas at San Antonio · USThe University of Texas Southwestern Medical Center · USTokyo Medical and Dental University · JPUniversity of Verona · IT

Funding

Training CoreU54HD087351 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI OLSON, ERIC N · 2015 to 2019
$7.8M
Posttranscriptional Regulation of RNA Binding Proteins in Heart FailureR01HL148733 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI GUO, WEI · 2020 to 2023
$1.5M
Maternal Obesity and Origin of Adult Offspring Cardiovascular DiseaseR03HD101870 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI GUO, WEI · 2020 to 2021
$155k
American Heart Association-American Stroke Association 16BGIA27790136American Heart Association-American Stroke Association 19TPA34830072NHLBI NIH HHS R01 HL148733NICHD NIH HHS U54 HD087351
6 · The paper itself

Abstract

Ribonucleoprotein (RNP) granules are biomolecular condensates-liquid-liquid phase-separated droplets that organize and manage messenger RNA metabolism, cell signaling, biopolymer assembly, biochemical reactions and stress granule responses to cellular adversity. Dysregulated RNP granules drive neuromuscular degenerative disease but have not previously been linked to heart failure. By exploring the molecular basis of congenital dilated cardiomyopathy (DCM) in genome-edited pigs homozygous for an RBM20 allele encoding the pathogenic R636S variant of human RNA-binding motif protein-20 (RBM20), we discovered that RNP granules accumulated abnormally in the sarcoplasm, and we confirmed this finding in myocardium and reprogrammed cardiomyocytes from patients with DCM carrying the R636S allele. Dysregulated sarcoplasmic RBM20 RNP granules displayed liquid-like material properties, docked at precisely spaced intervals along cytoskeletal elements, promoted phase partitioning of cardiac biomolecules and fused with stress granules. Our results link dysregulated RNP granules to myocardial cellular pathobiology and heart failure in gene-edited pigs and patients with DCM caused by RBM20 mutation.

Indexed as

AllelesAnimalsCardiomyopathy, DilatedCellular ReprogrammingDisease Models, AnimalFemaleGene EditingHumansMaleMutationMyocardiumMyocytes, CardiacRibonucleoproteinsRNA-Binding ProteinsRNA, MessengerSarcoplasmic Reticulumribonucleic acid binding motif protein 20, humanRibonucleoproteinsRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID33188278
PMCPMC9270981
OpenAlexW3106082682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.